72. Anxiety disorders and associated factors in patients with chronic urticaria

Huynh Nhu, Trinh Thi Hong Cua, Ly Kim Bich, Tran Quang Nhan, Nguyen Van Thong

Main Article Content

Abstract

Chronic urticaria is a disease with wheals, angioedema, or both that persists for more than six weeks. Anxiety disorders are commonly observed in this patient group, contributing to exacerbation of symptoms and further reduction in quality of life. This study aimed to determine the prevalence, symptoms of anxiety disorders, and analyze related factors in patients with chronic urticaria. A cross-sectional study was conducted on a convenience sample of 99 patients diagnosed with chronic urticaria. Disease activity was assessed using the Urticaria Activity Score over 7 days (UAS7), and anxiety disorders were evaluated using the Generalized Anxiety Disorder 7-item scale (GAD-7). The results showed a mean age of 35.81 ± 13.13 years old,  predominently female at 76.8%. The median UAS7 score was 14. The prevalence of anxiety disorders among patients with chronic urticaria was 31.3%, with nervousness (99.0%) and trouble relaxing (79.8%) being the most frequently reported symptoms. Disease activity was identified as an independent risk factor associated with anxiety (adjusted OR = 1.498; 95% CI: 1.243 – 1.804; p < 0.001). Anxiety disorders are common and should be evaluated and screened in the clinical assessment of patients with chronic urticaria.

Article Details

References

1. Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. Mar 2022; 77(3): 734-766. doi:10.1111/all.15090.
2. Gonçalo M, Gimenéz-Arnau A, Al-Ahmad M, et al. The global burden of chronic urticaria for the patient and society. Br J Dermatol. Feb 2021; 184(2): 226-236. doi:10.1111/bjd.19561.
3. Kang S, Amagai M, Bruckner AL, et al. Fitzpatrick’s Dermatology, 9e. McGraw-Hill Education; 2019: 684-709:chap 41. Urticaria and Angioedema.
4. Craske MG, Stein MB. Anxiety. Focus (Am Psychiatr Publ). Apr 2017; 15(2): 199-210. doi:10.1176/appi.focus.15203.
5. Tzur Bitan D, Berzin D, Cohen A. The association of chronic spontaneous urticaria (CSU) with anxiety and depression: a nationwide cohort study. Arch Dermatol Res. Jan 2021; 313(1): 33-39. doi:10.1007/s00403-020-02064-3.
6. Tat TS. Higher Levels of Depression and Anxiety in Patients with Chronic Urticaria. Med Sci Monit. Jan 4 2019; 25: 115-120. doi:10.12659/msm.912362.
7. Hide M, Uda A, Maki F, et al. Prevalence and Burden of Chronic Spontaneous Urticaria in Japan: A Cross-Sectional Study. J Clin Med. Feb 11 2025; 14(4). doi:10.3390/jcm14041162.
8. Vinogradova VV, Kivite-Urtane A, Vrublevska J, Rancans E. Anxiety Screening among the General Population of Latvia and Associated Factors. Medicina (Kaunas). Aug 26 2022; 58(9). doi:10.3390/medicina58091163.
9. Choi GS, Nam YH, Park CS, et al. Anxiety, depression, and stress in Korean patients with chronic urticaria. Korean J Intern Med. Nov 2020; 35(6): 1507-1516. doi:10.3904/kjim.2019.320.
10. Bộ Y Tế. Hướng dẫn chẩn đoán và điều trị các bệnh da liễu. Bệnh mày đay. 2023: 213-214.
11. Armstrong AW, Soong W, Bernstein JA. Chronic Spontaneous Urticaria: How to Measure It and the Need to Define Treatment Success. Dermatol Ther (Heidelb). Aug 2023; 13(8): 1629-1646. doi:10.1007/s13555-023-00955-7.
12. Sapra A, Bhandari P, Sharma S, Chanpura T, Lopp L. Using Generalized Anxiety Disorder-2 (GAD-2) and GAD-7 in a Primary Care Setting. Cureus. May 21 2020; 12(5): e8224. doi:10.7759/cureus.8224.
13. Preis S, Claussen C, Ziehfreund S, Biedermann T, Horster S, Zink A. Is there a difference between women and men in chronic spontaneous urticaria? A systematic review on gender and sex differences in CSU patients. World Allergy Organ J. Nov 2024; 17(11): 100974. doi:10.1016/j.waojou.2024.100974.
14. Huang Y, Xiao Y, Zhang X, Li J, Chen X, Shen M. A Meta-Analysis of Observational Studies on the Association of Chronic Urticaria With Symptoms of Depression and Anxiety. Front Med (Lausanne). 2020; 7:39. doi:10.3389/fmed.2020.00039.
15. Konstantinou GN, Konstantinou GN. Psychiatric comorbidity in chronic urticaria patients: a systematic review and meta-analysis. Clin Transl Allergy. 2019; 9: 42. doi:10.1186/s13601-019-0278-3.
16. Eskeland S, Halvorsen JA, Tanum L. Antidepressants have anti-inflammatory effects that may be relevant to dermatology: a systematic review. Acta dermato-venereologica. 2017; 97(8): 897-905.